Neoadjuvant therapy using PD-1 inhibitor plus chemotherapy with different intervals between chemotherapy cycles for locally advanced gastric or gastroesophageal junction cancer: A randomized phase 2 study

被引：0
|
作者：
Gao, Quanli
Zhao, Lingdi
Zhao, Weijie
Wang, Zibing
Qin, Peng
Jiang, Zhiqiang
Huang, Jinxi
Zhang, Bin
Li, Zhimeng
Fu, Qiang
Zhao, Yuzhou
Ren, Yingkun
Shang, Chuang
Wan, Xiangbin
Gao, Yang
Xu, Yongchao
Yuan, Long
Lu, Chaomin
Li, Zhi
机构：
[1] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Immunol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[3] Henan Canc Hosp, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[5] Zhengzhou Univ, Surg Oncol, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[6] Zhengzhou Univ, Dept Surg Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4064
引用
收藏
页数：1
相关论文
共 50 条
  • [31] KEYNOTE-585: randomized, phase 3 study of chemotherapy plus pembrolizumab vs chemotherapy plus placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer
    Bang, Yung-Jue
    Van Cutsem, Eric
    Fuchs, Charles
    Ohtsu, Atsushi
    Tabernero, Josep
    Ilson, David
    Hyung, Woo Jin
    Strong, Vivian
    Goetze, Thorsten
    Yoshikawa, Takaki
    Tang, Laura
    Sun, Linda
    Hasan, Aisha
    Koshiji, Minori
    Shitara, Kohei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [32] Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study
    Wang, Xin
    Zhao, Dong-Bing
    Yang, Lin
    Chi, Yihebali
    Zhao, Hong
    Jiang, Li-Ming
    Jiang, Jun
    Tang, Yuan
    Li, Ning
    Liu, Wen-Yang
    Dou, Li-Zhou
    Zou, Shuang-Mei
    Xue, Li-Yan
    Ren, Jian-Song
    Tian, Yan-Tao
    Che, Xu
    Guo, Chun-Guang
    Bai, Xiao-Feng
    Sun, Yue-Min
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Fang, Hui
    Li, Ye-Xiong
    Jin, Jing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] A multicenter, prospective study of apatinib plus chemotherapy as neoadjuvant treatment for locally advanced gastric cancer
    Tang, Y-H.
    Wang, F-H.
    Lin, G-J.
    Lin, J-X.
    Zheng, C-H.
    Li, P.
    Xie, J-W.
    Wang, J-B.
    Lu, J.
    Chen, Q-Y.
    Cao, L-L.
    Lin, M.
    Tu, R-H.
    Huang, Z-N.
    Lin, J-L.
    Zheng, H-L.
    Huang, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S1300 - S1300
  • [34] Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial
    Jian-Xian Lin
    Yi-Hui Tang
    Hua-Long Zheng
    Kai Ye
    Jian-Chun Cai
    Li-Sheng Cai
    Wei Lin
    Jian-Wei Xie
    Jia-Bin Wang
    Jun Lu
    Qi-Yue Chen
    Long-Long Cao
    Chao-Hui Zheng
    Ping Li
    Chang-Ming Huang
    Nature Communications, 15 (1)
  • [35] Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial
    Lin, Jian-Xian
    Tang, Yi-Hui
    Zheng, Hua-Long
    Ye, Kai
    Cai, Jian-Chun
    Cai, Li-Sheng
    Lin, Wei
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lu, Jun
    Chen, Qi-Yue
    Cao, Long-Long
    Zheng, Chao-Hui
    Li, Ping
    Huang, Chang-Ming
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [36] Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
    Verschoor, Yara L.
    van de Haar, Joris
    van den Berg, Jose G.
    van Sandick, Johanna W.
    Kodach, Liudmila L.
    van Dieren, Jolanda M.
    Balduzzi, Sara
    Grootscholten, Cecile
    Ijsselsteijn, Marieke E.
    Veenhof, Alexander A. F. A.
    Hartemink, Koen J.
    Vollebergh, Marieke A.
    Jurdi, Adham
    Sharma, Shruti
    Spickard, Erik
    Owers, Emilia C.
    Bartels-Rutten, Annemarieke
    den Hartog, Peggy
    de Miranda, Noel F. C. C.
    van Leerdam, Monique E.
    Haanen, John B. A. G.
    Schumacher, Ton N.
    Voest, Emile E.
    Chalabi, Myriam
    NATURE MEDICINE, 2024,
  • [37] Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma (LA HPSCC)
    Zhang, Y.
    Gao, W.
    Feng, L.
    Zhao, X.
    Huang, Z.
    Chen, D.
    Yin, G.
    Guo, W.
    ANNALS OF ONCOLOGY, 2024, 35
  • [38] Predictive biomarkers for the efficacy of PD-1 inhibitors plus chemotherapy for gastric/gastroesophageal junction cancer in first-line setting.
    Sun, Yu-Ting
    Lu, Shi-Xun
    Lai, Ming-Yu
    Yang, Xia
    Guan, Wen-Long
    Yang, Li-Qiong
    Li, Yu-Hong
    Wang, Feng-Hua
    Xu, Rui-Hua
    Qiu, Miao-Zhen
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study
    Yun Sun
    Yanan Fan
    Zhibin Ye
    Jiantao Dong
    Lifei Zhang
    Yanhui Peng
    Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1033 - 1040
  • [40] Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study
    Sun, Yun
    Fan, Yanan
    Ye, Zhibin
    Dong, Jiantao
    Zhang, Lifei
    Peng, Yanhui
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1033 - 1040
12345